Bøger af John Carreyrou

Elizabeth Holmes (f. 1984) har altid været bange for nåle. Hendes livsmission var at opfinde en nem og billig metode til at tage blodprøver, der kunne afdække en lang række sygdomme. Som 19-årig droppede hun ud af universitetet og stiftede biotekvirksomheden Theranos, der ti år senere blev vurderet til en værdi på ti milliarder dollars. I 2015 var hun USA’s både yngste og rigeste selvskabte kvindelige milliardær. En lang række af USA’s mest magtfulde folk lovpriste den ambitiøse iværksætter, der kom på forsiden af magasiner som Forbes og Fortune og blev udråbt som den kvindelige Steve Jobs. Der var kun ét problem. Hendes produkt virkede ikke. Det stoppede hende dog ikke. Hun afviste al kritik, fyrede alle medarbejdere, der sagde hende imod, og fortsatte med at markedsføre sit produkt over for investorer. Hun fik endda sit apparat ind i USA’s næststørste apotekerkæde, hvor amerikanerne fik taget blodprøver. Elizabeth Holmes og Theranos blev afsløret af bogens forfatter, John Carreyrou, der har interviewet over 150 personer til bogen, heriblandt 60 tidligere ansatte hos Theranos.Kåret til årets businessbog 2018 af Financial Times og McKinsey. Udnævnt til en af årtiets ti bedste nonfiktionbøger af The Times.

NEW YORK TIMES BEST SELLER *; NAMED ONE OF THE BEST BOOKS OF THE YEAR BY: NPR,The New York Times Book Review, Time, Wall Street Journal, Washington Post *; The McKinsey Business Book of the Year The full inside story of the breathtaking rise and shocking collapse of Theranos, the one-time multibillion-dollar biotech startup founded by Elizabeth Holmesnow the subject of the HBO documentary The Inventorby the prize-winning journalist who first broke the story and pursued it to the end. ';The story is even crazier than I expected, and I found myself unable to put it down once I started. This book has everything: elaborate scams, corporate intrigue, magazine cover stories, ruined family relationships, and the demise of a company once valued at nearly $10 billion.' Bill Gates In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup ';unicorn' promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. A riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.

"In 2014 Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup 'unicorn' promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier ... There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When [the author], working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both [he] and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"--

The shocking true story of the biggest corporate fraud since Enron, a gripping cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley.